NewAmsterdam Pharma Company N.V. Warrant (NAMSW) earnings · rev $22.5M
These earnings events as JSON? API free 100/dayNewAmsterdam Pharma Company N.V. Warrant (NAMSW) warrant listed on NASDAQ.
This NAMSW earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NAMSW revenue for 2025-12-31 was $22.5M. Net income was -$203.8M. Revenue was down 50.6% from 2024-12-31 to 2025-12-31. NAMSW currently screens at market cap $1.29B.
When the next NAMSW 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 50.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NAMSW research stays on the stock page; the tape stays on the quote page.
NAMSW earnings FAQ
What are NAMSW's latest revenue and net income?
Latest cached NewAmsterdam Pharma Company N.V. Warrant (NAMSW) revenue for Dec 31, 2025 was $22.5M. Net income was -$203.8M. Statements: https://lician.com/financials/namsw
What is NAMSW's latest diluted EPS?
Latest cached NewAmsterdam Pharma Company N.V. Warrant (NAMSW) diluted EPS for Dec 31, 2025 was -$1.72.
What period does the latest NAMSW earnings print cover?
The latest cached NewAmsterdam Pharma Company N.V. Warrant (NAMSW) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did NAMSW revenue change from the prior cached period?
Cached NewAmsterdam Pharma Company N.V. Warrant (NAMSW) revenue was down 50.6% from $45.6M (Dec 31, 2024) to $22.5M (Dec 31, 2025). Statements: https://lician.com/financials/namsw
Where are NAMSW earnings listed?
Cached earnings facts for NewAmsterdam Pharma Company N.V. Warrant (NAMSW) are listed at https://lician.com/earnings/namsw. Statements: https://lician.com/financials/namsw
Not investment advice.